George P Hemstreet, MD, PhD
Professor
![](https://dms.creighton.edu/sites/default/files/faculty-images/Hemstreet1.jpg)
Contact
School of Medicine
Department of Urology Fellowships
George P Hemstreet, MD, PhD
Professor
Teaching Interests
- Urologic Oncology, Immunology, Biomarkers in Molecular Biology
Department
Urology
Position
Professor
Books
- Bladder Tumors
Bishay John H., Intravesical Immunotherapy: BCG [Book Chapter] 2011 - Advances in Bladder Research
Hurst Robert E., Complexity, Retinoid-Responsive Gene Networks, and Bladder Carcinogenesis [Book Chapter] 1999 - Hemstreet George P, Selection and Development of Biomarkers for Bladder Cancer - 3 [Book Chapter] 1998
Publications
- The Prostate
Zhou Cindy Ke, Circulating and intraprostatic sex steroid hormonal profiles in relation to male pattern baldness and chest hair density among men diagnosed with localized prostate cancers
77:16, p. 1573 - 1582 2017 - Cancer epidemiology, biomarkers & prevention
Cook Michael B., Relationships between Circulating and Intraprostatic Sex Steroid Hormone Concentrations
26:11, p. 1660 - 1666 2017 - Journal of the National Comprehensive Cancer Network
Carroll Peter R., NCCN Guidelines Insights: Prostate Cancer Early Detection
14:5, p. 509 - 519 2016 - Journal of the National Comprehensive Cancer Network
Carroll Peter R., Prostate Cancer Early Detection, Version 2.2015 Clinical Practice Guidelines in Oncology
13:12, p. 1534 - 1561 2015 - Journal of the National Comprehensive Cancer Network
Carroll Peter R., Prostate Cancer Early Detection, Version 1.2014
12:9, p. 1211 - 1219 2014 - Journal of clinical oncology
Tandra Pavankumar, Sarcomatoid renal cell carcinoma (SRCC): University of Nebraska Medical Center experience
31:6_suppl, p. 472 - 472 2013 - Journal of immunotherapy (1997)
Hemstreet George P., Cellular Immunotherapy Study of Prostate Cancer Patients and Resulting IgG Responses to Peptide Epitopes Predicted From Prostate Tumor-associated Autoantigens
36:1, p. 57 - 65 2013 - Lasers in medical science
Kaushik Dharam, Novel treatment strategy for refractory hemorrhagic cystitis following radiation treatment of genitourinary cancer
27:5, p. 1099 - 1102 2012 - Urology (Ridgewood, N.J.)
Berglund Ryan K., Ten-year Follow-up of Neoadjuvant Therapy with Goserelin Acetate and Flutamide Before Radical Prostatectomy for Clinical T3 and T4 Prostate Cancer: Update on Southwest Oncology Group Study 9109
79:3, p. 633 - 637 2012 - Prostate cancer
Wang Jue, Younger Age Is an Independent Predictor for Poor Survival in Patients with Signet Ring Prostate Carcinoma
2011, p. 216169 - 8 2011 - Studies in health technology and informatics
Park Eugene S, The initiation of a preoperative and postoperative telemedicine urology clinic
163, p. 425 - 427 2011 - International braz j urol : official journal of the Brazilian Society of Urology
Villanueva Carlos, The approach to the difficult urethral catheterization among urology residents in the United States
36:6, p. 710 - 5; discussion 715-7 2010 - Rare tumors
Wang Jue, Clinical features and outcomes of 25 patients with primary adenosquamous cell carcinoma of the prostate
2:3, p. 130 - 134 2010 - Journal of the National Comprehensive Cancer Network
Kawachi Mark H, NCCN clinical practice guidelines in oncology: prostate cancer early detection
8:2, p. 240 - 262 2010 - The Journal of urology
Hemstreet George P., Editorial Comment
181:2, p. 553 - 553 2009 - International journal of cancer
Huang DALI, UDP-glucose dehydrogenase as a novel field-specific candidate biomarker of prostate cancer
126:2, p. 315 - 327 2009 - The Journal of urology
Chen Chung-Hsin, Clinicopathological Characteristics and Survival Outcome of Arsenic Related Bladder Cancer in Taiwan. Commentary
181:2, p. 547 - 553 2009 - International braz j urol : official journal of the Brazilian Society of Urology
Villanueva Carlos, Difficult male urethral catheterization: a review of different approaches
34:4, p. 401 - 11; discussion 412 2008 - Clinical cancer research
Sabichi Anita L., Phase III prevention trial of Fenretinide in patients with resected non-muscle-invasive bladder cancer
14:1, p. 224 - 229 2008 - The Journal of urology
Pisarev Vladimir M, VACCINATION OF PROSTATE CANCER PATIENTS WITH GENETICALLY MODIFIED ALLOGENEIC TUMOR CELL VACCINE INDUCES IgG RESPONSES TOWARD MULTIPLE PEPTIDE EPITOPES PREDICTED FROM COMMON PROSTATE TUMOR- ASSOCIATED AUTOANTIGENS
179:4S, p. 230 - 230 2008 - International journal of cancer
Carreon Tania, 'N-Acetyltransferases and the susceptibility to benzidine-induced bladder carcinogenesis' - Reply
121:7, p. 1637 - 1639 2007 - Cancer epidemiology, biomarkers & prevention
Huang DALI, Quantitative fluorescence imaging analysis for cancer biomarker discovery : Application to β-catenin in archived prostate specimens
16:7, p. 1371 - 1381 2007 - The Journal of urology
Hemstreet George P., 1717: Quantitative Fluorescence Imaging Analysis for Cancer Biomarker Discovery: Application to B-Catenin in Archived Prostate Specimens
177:4S, p. 571 - 571 2007 - Urology (Ridgewood, N.J.)
Habuchi Tomonori, Prognostic markers for bladder cancer: International Consensus Panel on bladder tumor markers
66:6, p. 64 - 74 2005 - Urologic oncology
Lewis Tamra E, Tissue transglutaminase interacts with protein kinase A anchor protein 13 in prostate cancer
23:6, p. 407 - 412 2005 - Urology (Ridgewood, N.J.)
Klingler Douglas W, Feasibility of robotic radical nephrectomy-initial results of single-institution pilot study
65:6, p. 1086 - 1089 2005 - Journal of clinical oncology
Hemstreet G. P., Fluorescence imaging proteometry of thymosin β4 in single cells for detection of bladder transitional cell carcinoma
23:16_suppl, p. 4745 - 4745 2005 - The Journal of urology
Lerner Seth P., 913: Results of a Randomized Chemoprevention Trial with Fenretinide in Non-Muscle Invasive Bladder Cancer
173:4S, p. 246 - 247 2005 - Cancer research (Chicago, Ill.)
Jaggi Meena, E-Cadherin Phosphorylation by Protein Kinase D1/Protein Kinase Cμ is Associated with Altered Cellular Aggregation and Motility in Prostate Cancer
65:2, p. 483 - 492 2005 - Urology (Ridgewood, N.J.)
Lokeshwar Vinata B, Bladder tumor markers beyond cytology : International consensus panel on bladder tumor markers
66:6A, p. 35 - 63 2005 - Frontiers in bioscience
Hemstreet George P, Genotypic and phenotypic biomarker profiles for individual risk assessment and cancer detection (lessons from bladder cancer risk assessment in symptomatic patients and workers exposed to benzidine)
9:1-3, p. 2671 - 2679 2004 - Internal medicine news (Short Hills, N.J. 1995)
Hemstreet George P, Is robotic-assisted surgery clearly superior for radical prostatectomy for prostate cancer?
37:12, p. 12 2004 - Urology
Balaji K. C., Feasibility of robot-assisted totally intracorporeal laparoscopic ileal conduit urinary diversion: Initial results of a single institutional pilot study
63:1, p. 51 - 55 2004 - European urology supplements : official journal of the European Association of Urology
Hemstreet George P, Biomarker profiles for individual risk assessment and prostate cancer prevention
2:6, p. 177 - 177 2003 - Anticancer research
Hurst Robert E., Matrix-dependent Plasticity of the Malignant Phenotype of Bladder Cancer Cells
23:4, p. 3119 - 3128 2003 - The Journal of urology
Wehbi Nizar K, Pan-cadherin as a high level phenotypic biomarker for prostate cancer
167:5, p. 2215 - 2221 2002 - BioTechniques
Rao Jian Yu, Protein Expression Analysis Using Quantitative Fluorescence Image Analysis on Tissue Microarray Slides
32:4, p. 924 - 932 2002 - JNCI : Journal of the National Cancer Institute
Hemstreet George, RESPONSE: Re: Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to Benzidine
93:19, p. 1492a - 1493 2001 - JNCI : Journal of the National Cancer Institute
Hemstreet George P., Biomarker Risk Assessment and Bladder Cancer Detection in a Cohort Exposed to Benzidine
93:6, p. 427 - 436 2001 - Cancer
Birckbichler Paul J., Loss of tissue transglutaminase as a biomarker for prostate adenocarcinoma
89:2, p. 412 - 423 2000 - Cancer detection and prevention
Hemstreet G P, Abnormal G-actin content in single prostate cells as a biomarker of prostate cancer
24:5, p. 464 - 472 2000 - The Journal of urology
Lianes P., Biomarker Study of Primary Nonmetastatic Versus Metastatic Invasive Bladder Cancer
161:5, p. 1716 - 1717 1999 - The Journal of urology
Birckbichler Paul J., EXPRESSION OF TISSUE TRANSGLUTAMINASE IN HUMAN DIABETIC KIDNEY TISSUE SECTIONS, p. 84 1999 - The Journal of urology
Hemstreet George P., BIOMARKERS IN THE PREMALIGNANT FIELD PREDICT INDIVIDUAL CANCER RISK, p. 153 1999 - The Journal of urology
Hemstreet George P., EXPRESSION AND PROGNOSTIC VALUE OF CD44 ISOFORMS IN TRANSITIONAL CELL CARCINOMA OF RENAL PELVIS AND URETER, p. 808 - 809 1999 - Molecular and cellular endocrinology
Waliszewski Przemyslaw, Retinoid signaling in immortalized and carcinoma-derived human uroepithelial cells
148:1, p. 55 - 65 1999 - Urologic oncology
Waliszewski Przemyslaw, Expression of sex steroid receptor genes and comodulation with retinoid signaling in normal human uroepithelial cells and bladder cancer cell lines
3:5, p. 141 - 147 1997 - Seminars in oncology
Bane B L, Pathology and staging of bladder cancer
23:5, p. 546 - 570 1996 - The Journal of urology
Mora L. B, Ancillary techniques in the followup of transitional cell carcinoma : A comparison of cytology, histology and deoxyribonucleic acid image analysis cytometry in 91 patients. Commentary
156:1, p. 49 - 55 1996 - Journal of immunotherapy (1997)
Whitehead Robert P., A Phase II Trial of Continuous-Infusion Recombinant Interleukin-2 in Patients with Advanced Renal Cell Carcinoma
18:2, p. 104 - 114 1995 - Environmental and molecular mutagenesis
Kusser Wolfgang C., p53 mutations in human bladder cancer
24:3, p. 156 - 160 1994 - Cancer
Bonner Rebecca B., Bladder cancer risk assessment with quantitative fluorescence image analysis of tumor markers in exfoliated bladder cells
72:8, p. 2461 - 2469 1993 - Proceedings of the National Academy of Sciences - PNAS
Rao Jian Yu, Alterations in Phenotypic Biochemical Markers in Bladder Epithelium During Tumorigenesis
90:17, p. 8287 - 8291 1993 - The Journal of urology
Kuebler J. Philip, Treatment of Metastatic Renal Cell Carcinoma with Recombinant Interleukin-2 in Combination with Vinblastine or Lymphokine-Activated Killer Cells
150:3, p. 814 - 820 1993 - Journal of occupational medicine
Bi WenFang, Field Molecular Epidemiology: Feasibility of Monitoring for the Malignant Bladder Cell Phenotype in a Benzidine-Exposed Occupational Cohort
35:1, p. 20 - 27 1993 - Proceedings of the National Academy of Sciences - PNAS
Rao JIAN YU, Alterations in phenotypic biochemical markers in bladder epitheliuum during tumorigenesis
90:17, p. 8287 - 8291 1993 - The Journal of urology
Hemstreet George P., Identification of a High Risk Subgroup of Grade 1 Transitional Cell Carcinoma Using Image Analysis Based Deoxyribonucleic Acid Ploidy Analysis of Tumor Tissue
146:6, p. 1525 - 1529 1991 - The Journal of urology
Moon Timothy D., Quantitative Fluorescence Image Analysis of Deoxyribonucleic Acid Ploidy in Urine From Normal Children
145:6, p. 1236 - 1237 1991 - Journal of occupational medicine
Marsh Gary M., A Protocol for Bladder Cancer Screening and Medical Surveillance among High-Risk Groups: The Drake Health Registry Experience
32:9, p. 881 - 886 1990 - Journal of occupational medicine
Hemstreet George P., Quantitative Fluorescence Image Analysis in Bladder Cancer Screening
32:9, p. 822 - 828 1990 - The American journal of surgery
McGowan Patrick F., Early detection of colorectal cancer by quantitative fluorescence image analysis of exfoliated cells
159:1, p. 172 - 177 1990 - Hurst R. E, Molecular and cellular biological approaches and techniques in the detection of bladder cancer and enhanced risk for bladder cancer in high-risk groups 1990
- International journal of cancer
Hemstreet George P., DNA hyperploidy as a marker for biological response to bladder carcinogen exposure
42:6, p. 817 - 820 1988 - The Journal of urology
Parry William L., Cancer Detection by Quantitative Fluorescence Image Analysis
139:2, p. 270 - 274 1988 - Toxicology and industrial health
Pitha Jan V., Occupational Hydrocarbon Exposure and Renal Histopathology
3:4, p. 491 - 506 1987 - International journal of cancer
Bass Rebecca A., DNA cytometry and cytology by quantitative fluorescence image analysis in symptomatic bladder cancer patients
40:5, p. 698 - 705 1987 - Gynecologic oncology
Smith Jeffrey J., Automated quantitative fluorescent image analysis of cervical cytology
28:3, p. 241 - 254 1987 - The Journal of urology
Hemstreet George P., 452 - Qfia in Defining Bladder Cancer Risk in High-Risk Cohorts and Management of Symptomatic Bladder Cancer Patients
137:6, p. 216A - 216A 1987 - The Journal of urology
Hemstreet George P., 475 - Interleukin 2 (IL-2) in the Management of Patients with Renal Cell Carcinoma
137:6, p. 222A - 222A 1987 - Chest
Gasbarra D., Automated Identification of Aneuploid Cells in Lung Cancer
91:3, p. 3s - 4s 1987 - Cancer
Schulte Paul A., Risk factors for bladder cancer in a cohort exposed to aromatic amines
58:9, p. 2156 - 2162 1986 - Journal of occupational medicine
Schulte Paul A., Optimal Management of Asymptomatic Workers at High Risk of Bladder Cancer
28:1, p. 13 - 17 1986 - International journal of cancer
Hemstreet George P., Quantitative fluorescence measurements of ao‐stained normal and malignant bladder cells
31:5, p. 577 - 585 1983 - The Journal of urology
Smalley R.V., A Phase II Evaluation of a 3-Drug Combination of Cyclophosphamide, Doxorubicin and 5-Fluorouracil and of 5-Fluorouracil in Patients with Advanced Bladder Carcinoma or Stage D Prostatic Carcinoma
125:2, p. 191 - 195 1981 - International journal of cancer
Hemstreet George P., Comparison of steroid receptor levels in renal‐cell carcinoma and autologous normal kidney
26:6, p. 769 - 775 1980 - Urology (Ridgewood, N.J.)
Griggs W.Phillips, Pathologic and immunologic considerations in malakoplakia
16:6, p. 638 - 645 1980 - Urology (Ridgewood, N.J.)
Older Robert A., Suspicious appearance of simple cyst caused by technical artifact
9:4, p. 466 - 468 1977 - Urology (Ridgewood, N.J.)
Sink James D., Technique to assure urinary drainage through nephrostoiviy tube
9:2, p. 185 - 185 1977
Awards
- Unemed New Invention Contributor 2009
UNMC - Citation for Meritorious Services to the Oklahoma City Bombing Victims
American Medical Association - Biological Markers in Urinary Toxicology
National Research Council, ed. Washington, DC - Honorable Visiting Professor
Department of Urological Oncology, Cancer Institute (Hospital)
Chinese Academy of Medical Sciences, Beijing, China - George Lynn Cross Research Professorship
The University of Oklahoma - Visiting Professor
Department of Urology, Chongging Cancer Institute, Beijing, China
Chinese Academy of Preventive Medicine - Young Investigators Award
NIH